Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$7.04
-2.2%
$4.88
$3.67
$7.61
$1.47B1.95549,076 shs983,195 shs
National HealthCare Co. stock logo
NHC
National HealthCare
$110.30
+0.4%
$102.52
$89.14
$137.53
$1.71B0.5858,883 shs34,469 shs
Talkspace, Inc. stock logo
TALK
Talkspace
$2.72
+5.8%
$2.62
$1.70
$4.36
$455.52M1.061.89 million shs1.30 million shs
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$18.02
-0.7%
$16.48
$9.90
$27.20
$1.47B0.42898,293 shs630,368 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-0.96%+0.70%+78.66%+34.58%+40.90%
National HealthCare Co. stock logo
NHC
National HealthCare
+0.50%+0.97%+12.92%+8.16%-13.34%
Talkspace, Inc. stock logo
TALK
Talkspace
0.00%-0.39%+0.78%-6.88%+48.55%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
+1.85%-3.77%+8.04%+32.70%+15.54%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
2.2678 of 5 stars
2.34.00.00.03.72.50.0
National HealthCare Co. stock logo
NHC
National HealthCare
N/AN/AN/AN/AN/AN/AN/AN/A
Talkspace, Inc. stock logo
TALK
Talkspace
3.7671 of 5 stars
3.53.00.00.02.53.31.9
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1.5977 of 5 stars
4.40.00.00.01.30.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
2.60
Moderate Buy$7.504.17% Upside
National HealthCare Co. stock logo
NHC
National HealthCare
0.00
N/AN/AN/A
Talkspace, Inc. stock logo
TALK
Talkspace
3.00
Buy$4.5065.14% Upside
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
2.89
Moderate Buy$37.00106.04% Upside

Current Analyst Ratings Breakdown

Latest TALK, NHC, VRDN, and AVAH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$5.50 ➝ $9.50
8/19/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$6.75 ➝ $8.00
8/12/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$5.00 ➝ $6.75
8/11/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$9.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$27.00 ➝ $30.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$45.00 ➝ $41.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $26.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$28.00 ➝ $32.00
8/6/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$36.00 ➝ $34.00
7/21/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$6.25 ➝ $6.00
7/16/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$6.00 ➝ $5.00
(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$2.02B0.74$0.16 per share44.34($0.06) per share-120.00
National HealthCare Co. stock logo
NHC
National HealthCare
$1.46B1.19$7.13 per share15.68$59.41 per share1.88
Talkspace, Inc. stock logo
TALK
Talkspace
$187.59M2.43$0.01 per share216.31$0.67 per share4.07
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$300K4,888.17N/AN/A$4.00 per share4.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-$10.93M$0.0890.31N/A0.85%-54.56%3.17%11/6/2025 (Estimated)
National HealthCare Co. stock logo
NHC
National HealthCare
$66.80M$6.7114.02N/A10.03%6.87%4.68%N/A
Talkspace, Inc. stock logo
TALK
Talkspace
$1.15M$0.02136.3214.34N/A1.41%2.48%2.11%11/4/2025 (Estimated)
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$269.95M-$3.83N/AN/AN/A-112,806.88%-78.95%-49.91%N/A

Latest TALK, NHC, VRDN, and AVAH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$1.00-$1.00N/A-$1.00$0.05 million$0.08 million
8/5/2025Q2 2025
Talkspace, Inc. stock logo
TALK
Talkspace
$0.01-$0.00-$0.01N/A$54.08 million$54.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/AN/AN/AN/AN/A
National HealthCare Co. stock logo
NHC
National HealthCare
$2.562.29%N/A38.15%10 Years
Talkspace, Inc. stock logo
TALK
Talkspace
N/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/AN/AN/AN/AN/A

Latest TALK, NHC, VRDN, and AVAH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/8/2025
National HealthCare Co. stock logo
NHC
National HealthCare
quarterly$0.642.5%9/30/20259/30/202510/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/A
1.09
1.09
National HealthCare Co. stock logo
NHC
National HealthCare
0.14
1.80
1.77
Talkspace, Inc. stock logo
TALK
Talkspace
N/A
6.51
6.51
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.04
11.01
11.01

Institutional Ownership

CompanyInstitutional Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
87.96%
National HealthCare Co. stock logo
NHC
National HealthCare
56.44%
Talkspace, Inc. stock logo
TALK
Talkspace
57.37%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
7.80%
National HealthCare Co. stock logo
NHC
National HealthCare
14.97%
Talkspace, Inc. stock logo
TALK
Talkspace
23.50%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1.58%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
33,500208.90 million192.60 millionOptionable
National HealthCare Co. stock logo
NHC
National HealthCare
12,40015.50 million13.32 millionN/A
Talkspace, Inc. stock logo
TALK
Talkspace
500167.47 million128.11 millionOptionable
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5081.66 million80.37 millionOptionable

Recent News About These Companies

Research Analysts Set Expectations for VRDN Q3 Earnings
HC Wainwright Issues Positive Estimate for VRDN Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aveanna Healthcare stock logo

Aveanna Healthcare NASDAQ:AVAH

$7.04 -0.16 (-2.22%)
Closing price 04:00 PM Eastern
Extended Trading
$7.04 +0.00 (+0.07%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

National HealthCare stock logo

National HealthCare NYSE:NHC

$110.30 +0.42 (+0.38%)
As of 04:00 PM Eastern

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Talkspace stock logo

Talkspace NASDAQ:TALK

$2.72 +0.15 (+5.84%)
Closing price 04:00 PM Eastern
Extended Trading
$2.70 -0.02 (-0.55%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.

Viridian Therapeutics stock logo

Viridian Therapeutics NASDAQ:VRDN

$18.02 -0.12 (-0.66%)
Closing price 04:00 PM Eastern
Extended Trading
$18.02 +0.00 (+0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.